Literature DB >> 1554035

Bizarre delusions and DSM-III-R schizophrenia.

D Goldman1, D A Hien, G L Haas, J A Sweeney, A J Frances.   

Abstract

OBJECTIVE: Bizarre delusions are assigned greater weight relative to other delusions in the DSM-III-R diagnosis of schizophrenia. The decision to emphasize bizarre delusions was based largely on historical tradition rather than empirical evidence. This study examined 1) the extent to which a history of bizarre delusions contributes to the diagnosis of schizophrenia and 2) whether schizophrenic patients with bizarre delusions constitute a clinically distinguishable subgroup.
METHOD: Two hundred fourteen consecutively admitted psychotic inpatients were assessed for bizarre delusions according to the DSM-III-R criteria. Clinical and demographic correlates of bizarre delusions were examined in subsets of patients diagnosed as schizophrenic according to DSM-III-R who also received CT scans and neuropsychological testing.
RESULTS: With the base prevalence rate for schizophrenia of 0.71, bizarre delusions had a sensitivity of 0.79, a specificity of 0.56, and a positive predictive power of 0.82 for the diagnosis of schizophrenia (N = 152) relative to other psychotic disorders (N = 62). Clinical, neurobehavioral, CT scan, and premorbid adjustment data on the schizophrenic patients indicated that beyond manifesting more severe positive symptoms, patients with bizarre delusions did not otherwise constitute a clinically distinguishable subgroup.
CONCLUSIONS: The data suggest that criterion A for the diagnosis of schizophrenia in DSM-IV could be improved by removing the special emphasis that was placed on bizarre delusions in DSM-III-R.

Entities:  

Mesh:

Year:  1992        PMID: 1554035     DOI: 10.1176/ajp.149.4.494

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

Review 1.  Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention.

Authors:  Jai L Shah; Neeraj Tandon; Matcheri S Keshavan
Journal:  Early Interv Psychiatry       Date:  2013-05-22       Impact factor: 2.732

Review 2.  What is bizarre in bizarre delusions? A critical review.

Authors:  M Cermolacce; L Sass; J Parnas
Journal:  Schizophr Bull       Date:  2010-02-08       Impact factor: 9.306

3.  Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?

Authors:  Stephen M Lawrie; Bayanne Olabi; Jeremy Hall; Andrew M McIntosh
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

4.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

5.  The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia.

Authors:  Ann K Shinn; Stephan Heckers; Dost Öngür
Journal:  Schizophr Res       Date:  2013-03-22       Impact factor: 4.939

6.  Inferior parietal lobule volume and schneiderian first-rank symptoms in antipsychotic-naïve schizophrenia: a 3-tesla MRI study.

Authors:  Vijay Danivas; Sunil Kalmady; Rashmi Arasappa; Rishikesh V Behere; Naren P Rao; Ganesan Venkatasubramanian; B N Gangadhar
Journal:  Indian J Psychol Med       Date:  2009-07

7.  Bizarre delusions: a qualitative study on Indian schizophrenia patients.

Authors:  Sreeja De; Triptish Bhatia; Pramod Thomas; Satabdi Chakraborty; Shiv Prasad; Rajesh Nagpal; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Indian J Psychol Med       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.